These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3276545)

  • 1. Autologous bone marrow transplantation in breast cancer: separation of clonogenic tumor cell colonies by gradient fractionation.
    Kies MS; Gordon LI; Rosen ST; Kucuk O; Vriesendorp HM
    Exp Hematol; 1988 Mar; 16(3):190-4. PubMed ID: 3276545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of clonogenic tumor cells from small cell lung cancer bone marrow and small cell lung cancer cell lines.
    Gordon LI; Rosen ST; Vriesendorp HM; Kies MS; Kucuk O
    Cancer Res; 1984 Nov; 44(11):5404-8. PubMed ID: 6091877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of small cell lung cancer bone marrow involvement by discontinuous gradient sedimentation.
    Hunter RF; Broadway P; Sun SL; Niell HB; Mauer AM
    Cancer Res; 1987 May; 47(10):2737-40. PubMed ID: 3032414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of malignant clonogenic breast cancer cells from human bone marrow.
    Anderson IC; Shpall EJ; Leslie DS; Nustad K; Ugelstad J; Peters WP; Bast RC
    Cancer Res; 1989 Aug; 49(16):4659-64. PubMed ID: 2663144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
    Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
    Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation.
    Shpall EJ; Bast RC; Joines WT; Jones RB; Anderson I; Johnston C; Eggleston S; Tepperberg M; Edwards S; Peters WP
    Bone Marrow Transplant; 1991 Feb; 7(2):145-51. PubMed ID: 2049558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Density gradient separation of hematopoietic stem cells in autologous bone marrow transplantation.
    Iacone A; Quaglietta AM; D'Antonio D; Accorsi P; Dragani A; Angrilli F; Berardi A; Angelini A; Di Bartolomeo P; Di Bartolomeo G
    Haematologica; 1991 Mar; 76 Suppl 1():18-21. PubMed ID: 1677910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of intensive clinic support to permit outpatient autologous bone marrow transplantation for breast cancer.
    Peters WP; Ross M; Vredenburgh JJ; Hussein A; Rubin P; Dukelow K; Cavanaugh C; Beauvais R; Kasprzak S
    Semin Oncol; 1994 Aug; 21(4 Suppl 7):25-31. PubMed ID: 7916487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation.
    Dietzfelbinger HF; Kühn D; Zafferani M; Hanauske AR; Rastetter JW; Berdel WE
    Cancer Res; 1993 Aug; 53(16):3747-51. PubMed ID: 8339286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Density-gradient separation for 4-hydroperoxycyclophosphamide purging of autologous bone marrow grafts.
    Rowley S; Davis J; Braine H; Jones R; Yeager A; Saral R; Santos G
    Prog Clin Biol Res; 1990; 333():369-77. PubMed ID: 2308991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purging of contaminating breast cancer cells from hematopoietic stem cell grafts by adenoviral GAL-TEK gene therapy and magnetic antibody cell separation.
    Marini FC; Snell V; Yu Q; Zhang X; Singletary SE; Champlin R; Andreeff M
    Clin Cancer Res; 1999 Jun; 5(6):1557-68. PubMed ID: 10389945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
    Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
    Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunopharmacologic purging of breast cancer from bone marrow for autologous bone marrow transplantation.
    Shpall EJ; Anderson IC; Bast RC; Joines WT; Jones RB; Ross M; Edwards S; Eggleston S; Johnston C; Tepperberg M
    Prog Clin Biol Res; 1990; 333():321-35; discussion 336. PubMed ID: 2308989
    [No Abstract]   [Full Text] [Related]  

  • 15. Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.
    Novitzky N; Mohamed R
    Exp Hematol; 1995 Dec; 23(14):1661-6. PubMed ID: 8542962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo manipulation of hematopoietic stem cells for transplantation: the potential role of amifostine.
    Balzarotti M; Grisanti S; Granzow K; Saladini A; Sala A; Nozza A; Molteni A; Passamonti F; Carlo-Stella C; Santoro A; Siena S
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):66-71. PubMed ID: 10348263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation support in a patient with breast cancer metastasis to bone marrow: immunocytochemical monitoring of cancer-cell contamination].
    Uno H; Fujita M; Hino N; Nakagawa H; Miyagawa H; Aoki J; Taniyama K; Sasaki N
    Rinsho Ketsueki; 1999 Jul; 40(7):556-62. PubMed ID: 10483138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The significance of tumor contamination in the bone marrow from high-risk primary breast cancer patients treated with high-dose chemotherapy and hematopoietic support.
    Vredenburgh JJ; Silva O; Broadwater G; Berry D; DeSombre K; Tyer C; Petros WP; Peters WP; Bast RC
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):91-7. PubMed ID: 9267669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of magnetic and chemocytotoxic cancer cell depletion for autologous bone marrow transplantation.
    Morecki S; Slavin S
    Isr J Med Sci; 1988; 24(9-10):488-93. PubMed ID: 3060442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
    Passos-Coelho J; Ross AA; Davis JM; Huelskamp AM; Clarke B; Noga SJ; Davidson NE; Kennedy MJ
    Cancer Res; 1994 May; 54(9):2366-71. PubMed ID: 8162582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.